Extended long term follow up confirms that coronary artery bypass grafting (CABG) is superior to percutaneous coronary intervention (PCI) with drug eluting stents (DES) for revascularisation in patients with type 2 diabetes and multivessel disease. The final report from the FREEDOM trial, which originally compared outcomes of the two strategies at four years, has now ...
Long term follow up confirms the preferred revascularisation strategy in diabetes
By Michael Woodhead
21 Nov 2018